Ultrasound Market

Ultrasound Market by Technology (Diagnostic (2D, 3D, Doppler), Therapeutic (HIFU, ESWL)), Display (Color, B&W), Portability (Trolley, POC), Application (Gynecology, Cardiology, Orthopedic), Component (Probe), End user (Hospitals) & Region - Global Forecasts to 2026

Report Code: MD 2885 Jan, 2022, by marketsandmarkets.com

Updated on : March 06, 2023

The global ultrasound market in terms of revenue was estimated to be worth $6.7 billion in 2021 and is poised to reach $9.0 billion by 2026, growing at a CAGR of 6.3% from 2021 to 2026. Ongoing technological advancements in the field of diagnostic & therapeutic ultrasound imaging, availability of medical reimbursements for diagnostic ultrasound procedures in mature markets, and the growing applications of emerging ultrasound techniques (such as Doppler ultrasound in vascular imaging and 3D/4D ultrasound in oncology) are driving the growth of market.

Ultrasound Market

To know about the assumptions considered for the study, Request for Free Sample Report

Ultrasound Market Growth Dynamics

Drivers: increasing prevalence of target diseases

The high and increasing incidence of target diseases and conditions will boost the adoption of effective diagnostic and therapeutic procedures. The burden of chronic and lifestyle diseases has increased in recent years. The burden of cancer, for example, was expected to increase from 14.1 million new cases in 2012 to 19.3 million new cases in 2020 (Source: GLOBOCAN, 2020).

As ultrasound technologies are cost-effective, safer, and offer earlier diagnosis & treatment of target diseases, their demand in disease management is expected to increase during the forecast period. Important statistics related to other major target diseases have been mentioned below:

  • According to the American Heart Association, by 2030, about 41.4% of US adults will have hypertension (an increase of 8.4% from 2012)
  • The burden of cancer, for example, is expected to increase from 14.1 million new cases to 18.1 million new cases during 2012– 2018 (Source: GLOBOCAN, 2018).
  • Globally, 415 million people had diabetes in 2015; by 2040, this figure will reach 642 million (Source: IDF Diabetes Atlas, 8th Edition). The number of diabetics in developing countries is expected to reach 228 million in 2025.

Restraints: Unfavorable healthcare reforms in the US

In August 2012, the US government planned to reduce Medicare spending by USD 716 billion over the next ten years (until 2022). Many industry participants expect that this health reform will negatively affect the cash flow for medical device companies operating in the US (including those involved in the manufacturing and marketing of ultrasound systems). This may limit the adoption of such devices in the US, as a number of healthcare facilities depend on government funds for purchasing high-end, highly expensive instruments. 

Opportunities: Expanding applications of ultrasound

Minimally invasive therapies and image-guided procedures are increasingly being adopted by healthcare professionals and patients across the world. The ultrasound industry has witnessed a significant shift from being a conventional diagnostic modality for OB/GYN imaging to a therapeutic technique for renal stones, cancers, and other clinical conditions. It can be expected that such efforts will open up new avenues for revenue growth for manufacturers in this market.

Challenges: Growing end-user preference for refurbished equipment

Due to the high prices of novel ultrasound technologies (such as focused ultrasound) and budgetary constraints faced by small-sized healthcare providers, the preference for refurbished ultrasound equipment has grown. For instance, a typical 3D/4D ultrasound system costs USD 20,000–75,000 in North America, while a refurbished 3D/4D ultrasound system costs USD 5,000–40,000. The growing preference for refurbished systems is, therefore, expected to pose a significant challenge to market growth.

Ultrasound Market Ecosystem:

Ultrasound Market by Ecosystem

To know about the assumptions considered for the study, download the pdf brochure

By technology, the 2D ultrasound segment to account for the largest share of the ultrasound market in 2020

Based on technology, the market is segmented into diagnostic ultrasound (2D, 3D & 4D, and Doppler ultrasound) and therapeutic ultrasound (focused ultrasound and shockwave lithotripsy). The diagnostic ultrasound segment is expected to account for the larger share of the market in 2020. The large share of this segment can be attributed to the significant usage of 2D ultrasound in women’s health, availability of medical reimbursements for diagnostic ultrasound procedures in mature markets, ongoing technological advancements in the field of diagnostic ultrasound imaging, and the growing applications of emerging ultrasound techniques.    

Trolley/cart-based ultrasound systems segment to account for the largest share of the ultrasound market, by system portability, in 2020

On the basis of system portability, the market is segmented into trolley/cart-based ultrasound systems, compact/handheld ultrasound systems, and point-of-care ultrasound systems. The trolley/cart-based ultrasound systems segment is expected to account for the largest share of the market in 2020. The large share of this segment is attributed to the growing adoption of these systems across major markets due to their increased usage in acute care settings and emergency care in hospitals and healthcare institutions.

By application, radiology/general imaging to account for the largest share of the ultrasound market in 2020

On the basis of application, the market is segmented into radiology/general imaging, obstetrics/gynecology, cardiologic applications, vascular applications, urological applications, orthopedic & musculoskeletal applications, pain management, and other applications. The radiology/general imaging applications segment is expected to command the largest share of the market in 2020. Factors such as the rising incidence of various cancers across major countries, technological advancements in the field of ultrasound-based diagnosis and treatment, growing market availability and physician preference for HIFU in cancer treatment, increasing usage of ultrasound in cancer diagnosis and tissue biopsy, and the rising adoption of focused ultrasound in disease therapies are driving the growth of the radiology/general imaging segment.

Hospitals, surgical centers, and diagnostic centers to dominate the ultrasound market, by end user, in 2020; this trend to continue during the forecast period

Based on end user, the market is segmented into hospitals, surgical centers, and diagnostic centers; maternity centers; ambulatory care centers; research and academia; and other end users. The hospitals, surgical centers, and diagnostic centers segment is expected to account for the largest share of the market in 2020. The large share of this segment can be attributed to factors such as a significant number of ultrasound-based medical procedures performed in hospitals, coupled with the growing number of hospitals across major markets, and rising adoption of minimally invasive diagnostic & surgical procedures in these facilities.

Ultrasound Market by Region

Europe is expected to command the largest share of the ultrasound market in 2020

The report covers the market across five major geographies, namely, Europe, North America, Asia Pacific, Latin America and MEA. Europe is expected to command the largest share of the market in 2020. Factors such as a large number of ongoing clinical research projects in the field of ultrasound, expansions in the clinical applications of focused ultrasound and the early commercialization of these devices in the region, and the significant healthcare expenditure across mature European countries (such as Germany, France, the UK, Italy, and Spain) are driving the growth of the market in Europe.

The major players in the ultrasound market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems (Japan), Siemens AG (Germany), Hitachi (Japan), Samsung Electronics (South Korea), and FUJIFILM Holdings Corporation (Japan). The other prominent players operating in this market include Esaote S.p.A. (Italy), Mindray Medical International Ltd. (China), Analogic Corporation (US), Carestream (US), Hologic (US), Mobisnate (US), and Chison Medical Imaging (China).

GE Healthcare (a key business division of General Electric Company) is among the top players engaged in the development and manufacturing of diagnostic ultrasound systems. The company focuses on maintaining its leadership position in the market through pipeline development and product commercialization. From 2018 to 2021, the market witnessed the commercialization of key ultrasound products by GE Healthcare, including the Versana Premier ultrasound system, Invenia Automated Breast Ultrasound (ABUS) 2.0 system, and Versana Essential ultrasound.

Ultrasound Market Report Scope:

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Technology, Device Display, System Portability, Application, Component, End User, and Region

Geographies covered

Europe, North America, the Asia Pacific, Latin America, and Middle East and Africa

Companies covered

GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Hitachi, Ltd. (Japan), Siemens Healthineers AG (Germany), Hologic, Inc. (US), FUJIFILM Holdings Corporation (Japan), Samsung Electronics Co., Ltd. (Korea), Mindray Medical International Limited (China), Analogic Corporation (US), Esaote S.p.A (Italy), Carestream Health (US), CURA Healthcare (India), Chison Medical Technologies Co., Ltd. (China), Mobisante, Inc. (US), Neusoft Corporation (China), Clarius Mobile Health (Canada), Medgyn Products, Inc. (US), and United Imaging Healthcare Co., Ltd. (China), among others  
 

This report has segmented the global ultrasound market into following segments & sub-segments:

By Technology

  • Diagnostic Ultrasound
    • 2D Ultrasound
    • 3D & 4D Ultrasound
    • Doppler Ultrasound
  • Therapeutic Ultrasound
    • High-Intensity Focused Ultrasound (HIFU)
    • Extracorporeal Shockwave Lithotripsy (ESWL)

By Device Display

  • Color Ultrasound
  • B/W Ultrasound

By Portability

  • Trolley/Cart-based Ultrasound Systems
  • Compact/Handheld Ultrasound Systems
  • Point-of-care (PoC) Ultrasound Systems

By Application

  • Radiology/General Imaging Applications
  • Obstetrics/Gynecology Applications
  • Cardiology Applications
  • Urology Applications
  • Vascular Applications
  • Orthopedic and Musculoskeletal Applications
  • Pain Management Applications
  • Other Applications (hepatology, neurology, bariatric surgery, breast imaging, and emergency care, among others)

By Component

  • Transducers/ Probes
    • Curvilinear/ Convex Array Probes
    • Linear Array Probes
    • Phased Array Probes
    • Other Probes
  • Workstations
  • Other components

By End User

  • Hospitals, Surgical Centers, and Diagnostic Centers
  • Maternity Centers
  • Ambulatory Care Centers
  • Research and Academia
  • Other End Users (physiotherapy clinics, independent associations, government organizations, and sports academies, among others)

By Region

  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
    • North America
    • US
    • Canada
  • Asia Pacific
    • Japan
    • China
    • India
    • India
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
  • Middle East & Africa

Recent Developments

  • In Sep 2021, GE Healthcare acquired BK Medical which extended GE Healthcare’s ultrasound portfolio into surgical visualization and boosted its growth in precision health.
  • In Mar 2021, Koninklijke Philips N.V. partnered with DiA Imaging Analysis Ltd.; Philips will utilize/integrate DiA’s automated solutions with ultrasound systems to deliver operational efficiency and access to care for POC customers in and out of hospitals.
  • In Dec 2020, Koninklijke Philips N.V. partnered with InSightec to expand access to MR-guided focused ultrasound for incision-less neurosurgery applications.
  • In Oct 2020, GE Healthcare partnered with St. Luke’s University; GE has installed 76 ultrasound units to standardize the care in radiology, vascular, and echocardiography applications.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
    1.1 OBJECTIVES OF THE STUDY
    1.2 ULTRASOUND MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY
    1.5 MARKET STAKEHOLDERS
    1.6 LIMITATIONS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 37)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
           FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 VENDOR REVENUE-BASED MARKET SIZE ESTIMATION
                    FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.2.2 END USER-BASED MARKET SIZE ESTIMATION
                    FIGURE 5 ULTRASOUND MARKET: END USER-BASED ESTIMATION
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 COVID-19 HEALTH ASSESSMENT
    2.4 COVID-19 ECONOMIC ASSESSMENT
    2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
           FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY
           FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
    2.6 DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.7 RESEARCH ASSUMPTIONS
    2.8 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 48)
    FIGURE 9 ULTRASOUND MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
    FIGURE 10 MARKET SHARE, BY DISPLAY TYPE, 2021 VS. 2026
    FIGURE 11 MARKET, BY SYSTEM PORTABILITY, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 MARKET SHARE, BY END USER, 2021 VS. 2026
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE MARKET

4 PREMIUM INSIGHTS (Page No. - 53)
    4.1 ULTRASOUND MARKET OVERVIEW
           FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE THE GROWTH OF THE MARKET
    4.2 EUROPE: DIAGNOSTIC MARKET, BY TYPE AND COUNTRY
           FIGURE 16 GERMANY IS THE LARGEST MARKET FOR DIAGNOSTIC ULTRASOUND IN EUROPE
    4.3 MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
           FIGURE 17 VASCULAR APPLICATIONS SEGMENT TO REGISTER SUBSTANTIAL GROWTH IN THE GLOBAL MARKET
    4.4 GEOGRAPHIC SNAPSHOT OF THE MARKET
           FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 56)
    5.1 INTRODUCTION
    5.2 ULTRASOUND MARKET DYNAMICS
           FIGURE 19 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing prevalence of target diseases
                    5.2.1.2 Rising patient preference for minimally invasive procedures
                    5.2.1.3 Technological advancements
                               TABLE 1 RECENT PRODUCT LAUNCHES/APPROVALS IN THE MARKET
                    5.2.1.4 Growing public and private investments, funding, and grants
                    5.2.1.5 Increasing number of diagnostic centers & hospitals
           5.2.2 RESTRAINTS
                    5.2.2.1 Unfavorable healthcare reforms in the US
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Expanding applications of therapeutic ultrasound
                    5.2.3.2 Emerging markets
                    5.2.3.3 Development of POC ultrasound devices
           5.2.4 CHALLENGES
                    5.2.4.1 Growing end-user preference for refurbished equipment
                    5.2.4.2 Dearth of skilled and well-trained sonographers
    5.3 INDUSTRY TRENDS
           5.3.1 DEVELOPMENT OF APPLICATION-SPECIFIC ULTRASOUND DEVICES
           5.3.2 GROWING USE OF ULTRASOUND IN ELASTOGRAPHY
           5.3.3 INCREASING USE OF MR-GUIDED ULTRASOUND MODALITIES IN NEUROLOGY APPLICATIONS
    5.4 PRICING TREND ANALYSIS (2017–2020)
           5.4.1 NORTH AMERICA
           5.4.2 EUROPE
           5.4.3 ASIA PACIFIC
           5.4.4 REST OF THE WORLD
    5.5 VALUE CHAIN ANALYSIS
           FIGURE 20 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE
    5.6 REGULATORY ANALYSIS
           5.6.1 NORTH AMERICA
                    5.6.1.1 US
                               TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
                               TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.6.1.2 Canada
                               TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                               FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
           5.6.2 EUROPE
                    FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
           5.6.3 ASIA PACIFIC
                    5.6.3.1 Japan
                               TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.6.3.2 China
                               TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.6.3.3 India
    5.7 PORTER’S FIVE FORCES ANALYSIS
           TABLE 7 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 THREAT OF SUBSTITUTES
           5.7.3 BARGAINING POWER OF SUPPLIERS
           5.7.4 BARGAINING POWER OF BUYERS
           5.7.5 DEGREE OF COMPETITION
    5.8 COVID-19 IMPACT ON THE MARKET
    5.9 ECOSYSTEM COVERAGE: MARKET
    5.10 PATENT ANALYSIS
           FIGURE 23 TOP 10 PATENT APPLICANTS FOR ULTRASOUND (DECEMBER 2021)
           FIGURE 24 PATENT APPLICATIONS FOR ULTRASOUND (JANUARY 2011 TO DECEMBER 2021)
           FIGURE 25 TOP 10 PATENT APPLICANTS FOR THERAPEUTIC ULTRASOUND (JANUARY 2011 TO AUGUST 2021)
           FIGURE 26 PATENT APPLICATIONS FOR THERAPEUTIC ULTRASOUND (JANUARY 2011 TO DECEMBER 2021)
           FIGURE 27 TOP 10 PATENT APPLICANTS FOR POINT-OF-CARE ULTRASOUND (JANUARY 2011 TO AUGUST 2021)
           FIGURE 28 PATENT APPLICATIONS FOR POINT-OF-CARE ULTRASOUND (JANUARY 2011 TO DECEMBER 2021)
    5.11 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS
           TABLE 8 IMPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)
           TABLE 9 EXPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)

6 ULTRASOUND MARKET, BY TECHNOLOGY (Page No. - 83)
    6.1 INTRODUCTION
           TABLE 10 ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
    6.2 DIAGNOSTIC ULTRASOUND
           TABLE 11 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 12 DIAGNOSTIC ULTRASOUND-MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.1 DIAGNOSTIC ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
                    TABLE 13 DIAGNOSTIC ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
           6.2.2 DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
                    TABLE 14 DIAGNOSTIC ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
           6.2.3 DIAGNOSTIC ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 15 DIAGNOSTIC ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           6.2.4 DIAGNOSTIC ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 16 DIAGNOSTIC ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
           6.2.5 2D ULTRASOUND
                    6.2.5.1 Strong market demand from less-developed and emerging countries to sustain the growth of this segment
                               TABLE 17 2D ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.6 2D ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
                    TABLE 18 2D ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
           6.2.7 2D ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
                    TABLE 19 2D ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
           6.2.8 2D ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 20 2D ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           6.2.9 2D ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 21 2D ULTRASOUND-, BY END USER, 2019–2026 (USD MILLION)
           6.2.10 3D AND 4D ULTRASOUND
                    6.2.10.1 Greater diagnostic accuracy and improved imaging capabilities to boost the global market demand for 3D/4D ultrasound
                                TABLE 22 3D AND 4D ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.11 3D AND 4D ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
                    TABLE 23 3D AND 4D ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
           6.2.12 3D AND 4D ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
                    TABLE 24 3D AND 4D ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
           6.2.13 3D AND 4D ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 25 3D AND 4D ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           6.2.14 3D AND 4D ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 26 3D AND 4D ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
           6.2.15 DOPPLER ULTRASOUND
                    6.2.15.1 Growing application in pain management, cardiovascular imaging, and emergency care to drive market growth
                                TABLE 27 DOPPLER ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.16 DOPPLER ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
                    TABLE 28 DOPPLER ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
           6.2.17 DOPPLER ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
                    TABLE 29 DOPPLER ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
           6.2.18 DOPPLER ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 30 DOPPLER ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           6.2.19 DOPPLER ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 31 DOPPLER ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
    6.3 THERAPEUTIC ULTRASOUND
           TABLE 32 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 33 THERAPEUTIC ULTRASOUND-MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.1 THERAPEUTIC ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
                    TABLE 34 THERAPEUTIC ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
           6.3.2 THERAPEUTIC ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
                    TABLE 35 THERAPEUTIC ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
           6.3.3 THERAPEUTIC ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 36 THERAPEUTIC ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           6.3.4 THERAPEUTIC ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 37 THERAPEUTIC ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
           6.3.5 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
                    6.3.5.1 Growing emphasis on the minimally invasive treatment of kidney and gall bladder stones to drive the demand for ESWL
                               TABLE 38 ESWL ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.6 ESWL ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
                    TABLE 39 ESWL ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
           6.3.7 ESWL ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
                    TABLE 40 ESWL ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
           6.3.8 ESWL ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 41 ESWL ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           6.3.9 ESWL ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 42 ESWL ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
           6.3.10 HIGH-INTENSITY FOCUSED ULTRASOUND
                    6.3.10.1 Promising results associated with HIFU for the treatment of various cancers to drive market growth
                                TABLE 43 HIFU ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.11 HIFU ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
                    TABLE 44 HIFU ULTRASOUND-MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
           6.3.12 HIFU ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
                    TABLE 45 HIFU ULTRASOUND-MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
           6.3.13 HIFU ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 46 HIFU ULTRASOUND-MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           6.3.14 HIFU ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 47 HIFU ULTRASOUND-MARKET, BY END USER, 2019–2026 (USD MILLION)

7 ULTRASOUND MARKET, BY SYSTEM PORTABILITY (Page No. - 106)
    7.1 INTRODUCTION
           TABLE 48 ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
    7.2 TROLLEY/CART-BASED DEVICES
           7.2.1 INCREASED USE OF TROLLEY-BASED SYSTEMS FOR ACUTE CARE & EMERGENCY CARE TO DRIVE MARKET GROWTH
                    TABLE 49 MARKET FOR TROLLEY/CART-BASED DEVICES, BY REGION, 2019–2026 (USD MILLION)
    7.3 COMPACT/TABLE-TOP DEVICES
           7.3.1 DEVICE AFFORDABILITY AS WELL AS PROCEDURAL & TECHNICAL BENEFITS TO DRIVE THE DEMAND FOR TABLE-TOP DEVICES
                    TABLE 50 MARKET FOR COMPACT/TABLE-TOP DEVICES, BY REGION, 2019–2026 (USD MILLION)
    7.4 POC/PORTABLE DEVICES
           7.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST THE DEMAND FOR POC ULTRASOUND DEVICES
                    TABLE 51 ULTRASOUND MARKET FOR POC/PORTABLE DEVICES, BY REGION, 2019–2026 (USD MILLION)

8 ULTRASOUND MARKET, BY DISPLAY TYPE (Page No. - 111)
    8.1 INTRODUCTION
           TABLE 52 ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
    8.2 COLOR ULTRASOUND DEVICES
           8.2.1 GREATER MARKET AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE THE MARKET
                    TABLE 53 COLOR ULTRASOUND DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
    8.3 BLACK & WHITE ULTRASOUND DEVICES
           8.3.1 ASIA PACIFIC REGION TO REGISTER SUSTAINED DEMAND FOR B/W ULTRASOUND DEVICES
                    TABLE 54 BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)

9 ULTRASOUND MARKET, BY APPLICATION (Page No. - 115)
    9.1 INTRODUCTION
           TABLE 55 MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    9.2 RADIOLOGY/GENERAL IMAGING APPLICATIONS
           9.2.1 GROWING NUMBER OF IMAGE-GUIDED SURGERIES/RADIOLOGY PROCEDURES TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
                    TABLE 56 ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
    9.3 CARDIOLOGY APPLICATIONS
           9.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
                    TABLE 57 MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
    9.4 OBSTETRICS/GYNECOLOGY APPLICATIONS
           9.4.1 ULTRASOUND IS WIDELY USED IN THE FIELD OF OBSTETRICS AND GYNECOLOGY
                    TABLE 58 MARKET FOR OBSTETRICS/GYNECOLOGY APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
    9.5 VASCULAR APPLICATIONS
           9.5.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
                    TABLE 59 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
    9.6 UROLOGICAL APPLICATIONS
           9.6.1 ULTRASOUND IS WIDELY USED IN THE DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS
                    TABLE 60 MARKET FOR UROLOGICAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
    9.7 ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS
           9.7.1 RISING PATIENT PREFERENCE FOR EFFECTIVE & EARLY DISEASE DIAGNOSIS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
                    TABLE 61 MARKET FOR ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
    9.8 PAIN MANAGEMENT APPLICATIONS
           9.8.1 ULTRASOUND DEVICES ARE INCREASINGLY BEING UTILIZED FOR TRAUMA & EMERGENCY CARE APPLICATIONS
                    TABLE 62 MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
    9.9 OTHER APPLICATIONS
           TABLE 63 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)

10 ULTRASOUND MARKET, BY COMPONENT (Page No. - 124)
     10.1 INTRODUCTION
             TABLE 64 MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
     10.2 TRANSDUCERS/PROBES
             TABLE 65 TRANSDUCERS/PROBES MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 66 TRANSDUCERS/PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)
             10.2.1 CURVILINEAR/CONVEX ARRAY PROBES
                        10.2.1.1 Growing adoption of POC ultrasound to drive the growth of this market segment
                                     TABLE 67 CURVILINEAR/CONVEX ARRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)
             10.2.2 LINER ARRAY PROBES
                        10.2.2.1 Increasing target patient population to drive the growth of this market segment
                                     TABLE 68 LINEAR ARRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)
             10.2.3 PHASED ARRAY PROBES
                        10.2.3.1 Technological advancements to drive the growth of this market segment
                                     TABLE 69 PHASED ARRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)
             10.2.4 OTHER PROBES
                        TABLE 70 OTHER PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)
     10.3 WORKSTATIONS
             10.3.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
                        TABLE 71 WORKSTATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
     10.4 OTHER COMPONENTS
             TABLE 72 OTHER COMPONENTS MARKET, BY REGION, 2019–2026 (USD MILLION)

11 ULTRASOUND MARKET, BY END USER (Page No. - 131)
     11.1 INTRODUCTION
           TABLE 73 ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)
     11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS
             11.2.1 SIGNIFICANT NUMBER OF ULTRASOUND-BASED MEDICAL PROCEDURES ARE PERFORMED IN THESE FACILITIES
                        TABLE 74 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2019–2026 (USD MILLION)
     11.3 MATERNITY CENTERS
             11.3.1 INCREASED ADOPTION OF ADVANCED 3D, 4D, AND DOPPLER ULTRASOUND FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH
                        TABLE 75 ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION, 2019–2026 (USD MILLION)
     11.4 AMBULATORY CARE CENTERS
             11.4.1 GROWING NUMBER OF MINIMALLY INVASIVE PROCEDURES PERFORMED AT AMBULATORY CARE CENTERS TO DRIVE MARKET GROWTH
                        TABLE 76 ULTRASOUND MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2026 (USD MILLION)
     11.5 RESEARCH AND ACADEMIA
             11.5.1 GROWING RESEARCH GRANTS AND FUNDING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                        TABLE 77 ULTRASOUND MARKET FOR RESEARCH AND ACADEMIA, BY REGION, 2019–2026 (USD MILLION)
     11.6 OTHER END USERS
             FIGURE 29 NUMBER OF SPORTS INJURIES (2020)
             TABLE 78 ULTRASOUND MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)

12 ULTRASOUND MARKET, BY REGION (Page No. - 139)
     12.1 INTRODUCTION
             TABLE 79 MARKET, BY REGION, 2019–2026 (USD MILLION)
     12.2 EUROPE
             FIGURE 30 EUROPE: ULTRASOUND MARKET SNAPSHOT
             TABLE 80 EUROPE: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 81 EUROPE: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
             TABLE 82 EUROPE: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 83 EUROPE: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 84 EUROPE: MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
             TABLE 85 EUROPE: MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
             TABLE 86 EUROPE: ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 87 EUROPE: MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 88 EUROPE: MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 89 EUROPE: ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)
             12.2.1 GERMANY
                        12.2.1.1 Wide acceptance of advanced technologies and favorable reimbursement scenario to drive market growth
                                     TABLE 90 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 91 GERMANY: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 92 GERMANY: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.2.2 UK
                        12.2.2.1 Rising geriatric population to drive market growth in the UK
                                     TABLE 93 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 94 UK: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 95 UK: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.2.3 FRANCE
                        12.2.3.1 Modernization of healthcare infrastructure fueling the demand for ultrasound systems
                                     TABLE 96 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 97 FRANCE: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 98 FRANCE: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.2.4 ITALY
                        12.2.4.1 Improved reimbursement scenario and increasing R&D to support overall market growth
                                     TABLE 99 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 100 ITALY: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 101 ITALY: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.2.5 SPAIN
                        12.2.5.1 Low entry barriers to create opportunities for global players to expand their presence in the country
                                     TABLE 102 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 103 SPAIN: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 104 SPAIN: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.2.6 REST OF EUROPE
                        TABLE 105 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                        TABLE 106 REST OF EUROPE: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 107 REST OF EUROPE: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
     12.3 NORTH AMERICA
             TABLE 108 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 109 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
             TABLE 110 NORTH AMERICA: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 111 NORTH AMERICA: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 112 NORTH AMERICA: MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
             TABLE 113 NORTH AMERICA: MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
             TABLE 114 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 115 NORTH AMERICA: MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 116 NORTH AMERICA: MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 117 NORTH AMERICA: ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)
             12.3.1 US
                        12.3.1.1 The US dominated the North American ultrasound market
                                     TABLE 118 POCUS ULTRASOUND CPT CODES (2021)
                                     TABLE 119 CPT CODES FOR ULTRASOUND-GUIDED PROCEDURES (2021)
                                     TABLE 120 US: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 121 US: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 122 US: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.3.2 CANADA
                        12.3.2.1 Growing awareness about early disease diagnosis to drive market growth in Canada
                                     TABLE 123 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 124 CANADA: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 125 CANADA: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
     12.4 ASIA PACIFIC
             FIGURE 31 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT
             TABLE 126 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 127 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
             TABLE 128 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 129 ASIA PACIFIC: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 130 ASIA PACIFIC: MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
             TABLE 131 ASIA PACIFIC: MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
             TABLE 132 ASIA PACIFIC: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 133 ASIA PACIFIC: ULTRASOUND MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 134 ASIA PACIFIC: MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 135 ASIA PACIFIC: MARKET, BY END USER, 2019–2026 (USD MILLION)
             12.4.1 CHINA
                        12.4.1.1 Increasing patient pool and localized manufacturing to drive the market growth
                                     TABLE 136 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 137 CHINA: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 138 CHINA: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.4.2 JAPAN
                        12.4.2.1 Rising geriatric population to boost market growth in Japan
                                     TABLE 139 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 140 JAPAN: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 141 JAPAN: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.4.3 INDIA
                        12.4.3.1 Significant burden of target diseases and availability of affordable devices to drive market growth
                                     TABLE 142 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 143 INDIA: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 144 INDIA: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.4.4 SOUTH KOREA
                        12.4.4.1 Supportive government initiatives in the country to positively impact market growth
                                     TABLE 145 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 146 SOUTH KOREA: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 147 SOUTH KOREA: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.4.5 AUSTRALIA
                        12.4.5.1 Growing research investments and awareness campaigns to drive market growth in Australia
                                     TABLE 148 AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO
                                     TABLE 149 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 150 AUSTRALIA: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 151 AUSTRALIA: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.4.6 REST OF ASIA PACIFIC
                        TABLE 152 ROAPAC: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                        TABLE 153 ROAPAC: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 154 ROAPAC: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
     12.5 LATIN AMERICA
             TABLE 155 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 156 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
             TABLE 157 LATIN AMERICA: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 158 LATIN AMERICA: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 159 LATIN AMERICA: MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
             TABLE 160 LATIN AMERICA: MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
             TABLE 161 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 162 LATIN AMERICA: MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 163 LATIN AMERICA: MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 164 LATIN AMERICA: ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION)
             12.5.1 BRAZIL
                        12.5.1.1 Universal healthcare system to play a pivotal role in driving the use of ultrasound for disease diagnosis
                                     TABLE 165 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 166 BRAZIL: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 167 BRAZIL: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.5.2 MEXICO
                        12.5.2.1 Modernization of healthcare infrastructure to support market growth in Mexico
                                     TABLE 168 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                     TABLE 169 MEXICO: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                     TABLE 170 MEXICO: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
             12.5.3 REST OF LATIN AMERICA
                        TABLE 171 ROLA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                        TABLE 172 ROLA: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 173 ROLA: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
     12.6 MIDDLE EAST & AFRICA
             12.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA REGION
                        TABLE 174 MEA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                        TABLE 175 MEA: DIAGNOSTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 176 MEA: THERAPEUTIC ULTRASOUND-MARKET, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 177 MEA: MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION)
                        TABLE 178 MEA: MARKET, BY SYSTEM PORTABILITY, 2019–2026 (USD MILLION)
                        TABLE 179 MEA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 180 MEA: ULTRASOUND MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                        TABLE 181 MEA: MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019–2026 (USD MILLION)
                        TABLE 182 MEA: MARKET, BY END USER, 2019–2026 (USD MILLION)

13 COMPETITIVE LANDSCAPE (Page No. - 201)
     13.1 OVERVIEW
     13.2 KEY PLAYER STRATEGIES
             FIGURE 32 KEY DEVELOPMENTS IN THE ULTRASOUND MARKET (2018 TO 2021)
     13.3 REVENUE SHARE ANALYSIS
             FIGURE 33 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE MARKET
     13.4 MARKET SHARE ANALYSIS: MARKET, BY KEY PLAYER (2020)
             FIGURE 34 GE HEALTHCARE HELD THE LEADING POSITION IN THE MARKET IN 2020
             TABLE 183 ULTRASOUND MARKET: DEGREE OF COMPETITION
     13.5 COMPANY EVALUATION QUADRANT FOR 25 KEY PLAYERS (2020)
             13.5.1 TERMINOLOGY/NOMENCLATURE
                        13.5.1.1 Stars
                        13.5.1.2 Emerging leaders
                        13.5.1.3 Pervasive players
                        13.5.1.4 Participants
                                     FIGURE 35 MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
     13.6 COMPANY EVALUATION QUADRANT FOR START-UP/SMES (2020)
             13.6.1 PROGRESSIVE COMPANIES
             13.6.2 RESPONSIVE COMPANIES
             13.6.3 DYNAMIC COMPANIES
             13.6.4 STARTING BLOCKS
                        FIGURE 36 MARKET: COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS)
     13.7 COMPETITIVE BENCHMARKING
             TABLE 184 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE MARKET
     13.8 COMPETITIVE SCENARIO (2018–2021)
             13.8.1 NEW PRODUCT LAUNCHES AND APPROVALS
                        TABLE 185 ULTRASOUND MARKET: NEW PRODUCT LAUNCHES AND APPROVALS, 2018–2021
             13.8.2 DEALS
                        TABLE 186 ULTRASOUND MARKET: DEALS, 2018–2021
             13.8.3 EXPANSIONS
                        TABLE 187 ULTRASOUND MARKET: EXPANSIONS, 2018–2021

14 COMPANY PROFILES (Page No. - 213)
     14.1 INTRODUCTION
     14.2 KEY PLAYERS
(Business overview, Products offered, Recent developments, MNM view)* 
             14.2.1 GE HEALTHCARE
                        TABLE 188 GE HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2020)
             14.2.2 KONINKLIJKE PHILIPS N.V.
                        TABLE 189 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                        FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
             14.2.3 CANON MEDICAL SYSTEMS CORPORATION
                        TABLE 190 CANON MEDICAL SYSTEMS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 39 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2020)
             14.2.4 SIEMENS AG
                        TABLE 191 SIEMENS AG: BUSINESS OVERVIEW
                        FIGURE 40 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
             14.2.5 HITACHI, LTD.
                        TABLE 192 HITACHI, LTD.: BUSINESS OVERVIEW
                        FIGURE 41 HITACHI, LTD.: COMPANY SNAPSHOT
             14.2.6 HOLOGIC, INC.
                        TABLE 193 HOLOGIC, INC.: BUSINESS OVERVIEW
                        FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT
             14.2.7 FUJIFILM HOLDINGS CORPORATION
                        TABLE 194 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 43 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
             14.2.8 SAMSUNG ELECTRONICS CO., LTD.
                        TABLE 195 SAMSUNG ELECTRONICS CO., LTD.: BUSINESS OVERVIEW
                        FIGURE 44 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT
             14.2.9 MINDRAY MEDICAL INTERNATIONAL LIMITED
                        TABLE 196 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
                        FIGURE 45 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT
             14.2.10 ANALOGIC CORPORATION
                        TABLE 197 ANALOGIC CORPORATION: BUSINESS OVERVIEW
             14.2.11 ESAOTE SPA
                        TABLE 198 ESAOTE S.P.A: BUSINESS OVERVIEW
             14.2.12 CARESTREAM HEALTH
                        TABLE 199 CARESTREAM HEALTH: BUSINESS OVERVIEW
                        FIGURE 46 ONEX CORPORATION: COMPANY SNAPSHOT
             14.2.13 CURA HEALTHCARE
                        TABLE 200 CURA HEALTHCARE: BUSINESS OVERVIEW
             14.2.14 CHISON MEDICAL TECHNOLOGIES CO., LTD.
                        TABLE 201 CHISON MEDICAL TECHNOLOGIES CO., LTD.: BUSINESS OVERVIEW
     *Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies. 
     14.3 OTHER COMPANIES
             14.3.1 MOBISANTE, INC.
             14.3.2 NEUSOFT CORPORATION
             14.3.3 CLARIUS MOBILE HEALTH
             14.3.4 MEDGYN PRODUCTS, INC.
             14.3.5 UNITED IMAGING HEALTHCARE CO., LTD.
             14.3.6 PROMED TECHNOLOGY CO., LTD.
             14.3.7 CEPHASONICS
             14.3.8 UAB TELEMED
             14.3.9 SHENZHEN RICSO TECHNOLOGY CO., LTD.
             14.3.10 WUHAN YOUKEY BIO-MEDICAL ELECTRONICS CO., LTD.

15 APPENDIX (Page No. - 268)
     15.1 DISCUSSION GUIDE
     15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     15.3 AVAILABLE CUSTOMIZATIONS
     15.4 RELATED REPORTS
     15.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the ultrasound market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Primary research was conducted after acquiring extensive knowledge about the global ultrasound market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as diagnostic centers, doctors, professors, and hospitals) and supply-side respondents (such as ultrasound device manufacturers and distributors) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East, and Africa. Approximately 60% of the primary interviews were conducted with stakeholders from the demand side while those from the supply side accounted for the remaining 40%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:

Ultrasound Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

A detailed market estimation approach was followed to estimate and validate the size of the global ultrasound market and other dependent submarkets.

  • The key players in the global market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights on the global market.
  • All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.
  •  All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Ultrasound Market Size, and Methodology

Data Triangulation:

After deriving the overall ultrasound market value data from the market size estimation process, the total market value data was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various qualitative and quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macroindicators.

Report Objectives:

  • To define, describe, and forecast the ultrasound market on the basis of technology, device display, system portability, application, component, end user, and region
  • To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global market
  • To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments and/or subsegments with respect to four major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), and the Rest of the World (Latin America, the Middle East, and Africa)
  • To profile the key players in the global market and comprehensively analyze their market shares and core competencies
  • To track and analyze the competitive developments undertaken in the global market, such as product launches; agreements, partnerships, and collaborations; expansions; and mergers & acquisitions

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global ultrasound market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe market into Belgium, Austria, the Czech Republic, Denmark, Greece, Poland, and Russia, among other
  • Further breakdown of the Rest of Asia Pacific market into wan, New Zealand, Vietnam, the Philippines, Singapore, Malaysia, Thailand, and Indonesia among other
  • Further breakdown of the Latin American market into Argentina, Chile, Peru, and Colombia, among other
Report Code
MD 2885
Published ON
Jan, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Ultrasound Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback